Submit Manuscripts
Author Information
Subscribe/Renew
Email Alerts
Feedback
RSS Feed

About the Journal
Editorial Board & Staff

Interventions Homepage Imaging Homepage Interventions Homepage Imaging Homepage

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions


Intensive Glycemic Control and the Prevention of Cardiovascular Events: Expert Consensus Document

2009 Appropriateness Criteria for Coronary Revascularization
cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2001; 38:1994-2000
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xin, J.
Right arrow Articles by Thomas, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xin, J.
Right arrow Articles by Thomas, J. D.

Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery1,2

Jian Xin, MDa, Takahiro Shiota, MD, PhD, FACCa, Harry M. Lever, MD, FACC*,a, Samir R. Kapadia, MDa, Marta Sitges, MDa, David N. Rubin, MDa, Fabrice Bauer, MDa, Neil L. Greenberg, PhDa, Deborah A. Agler, RDCSa, Jeanne K. Drinko, RDCSa, Maureen Martina, Murat Tuzcu, MD, FACCa, Nicholas G. Smedira, MD, FACCa, Bruce Lytle, MD, FACCa and James D. Thomas, MD, FACCa

a Cardiovascular Imaging Center, Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA



View larger version (32K):

[in a new window]
  		Figure 1 Resting pressure gradients (PG) before and immediately after percutaneous transluminal septal myocardial ablation (A) or myectomy (B) and at three-month follow-up in patients with resting PG ≥50 mm Hg. *in comparison with PGs before procedure, p < 0.0001.

 


View larger version (33K):

[in a new window]
  		Figure 2 Provokable pressure gradients (PG) before and immediately after percutaneous transluminal septal myocardial ablation (A) or myectomy (B) and at three-month follow-up in patients with resting PG <50 mm Hg. In comparison with PGs before procedure, *p < 0.0001; {dagger}p < 0.001; {ddagger}p = 0.03.

 


View larger version (12K):

[in a new window]
  		Figure 3 Comparison of average pressure gradients (PG) between percutaneous transluminal septal myocardial ablation (PTSMA) and myectomy group.

 


View larger version (11K):

[in a new window]
  		Figure 4 Improvements in New York Heart Association (NYHA) functional class after percutaneous transluminal septal myocardial ablation and myectomy in patients with hypertrophic obstructive cardiomyopathy.

 
 
  cardiology careers collections past issues search home